[The REALIST (REsiduAl risk, LIpids and Standard Therapies) study: an analysis of residual risk attributable to lipid profile in acute coronary syndrome].

Authors :: Millán Núñez-Cortés J
Montoya JP
Salas XP
Hernández Mijares A
Carey VJ
Hermans MP
Sacks FM
Fruchart JC
Source :: Endocrinologia y nutricion : organo de la Sociedad Espanola de Endocrinologia y Nutricion [Endocrinol Nutr] 2011 Jan; Vol. 58 (1), pp. 38-47. Date of Electronic Publication: 2011 Jan 03.
Publication Year :: 2011
Abstract: The R3i Foundation (Residual Risk Reduction Initiative), an independent, multinational and academic organization, is conducting the REALIST (Residual Risk, Lipids and Standard Therapies) study in 40 centers in different countries. This is a retrospective epidemiological study, designed to provide new data on the residual risk of major coronary events attributable to lipid abnormalities in patients receiving the current standard treatment. The initial results are expected in mid 2010, and the overall results at the end of 2010.<br /> (Copyright © 2010 SEEN. Published by Elsevier Espana. All rights reserved.)

Language :: Spanish; Castilian
ISSN :: 1579-2021
Volume :: 58
Issue :: 1
Database :: MEDLINE
Journal :: Endocrinologia y nutricion : organo de la Sociedad Espanola de Endocrinologia y Nutricion
Publication Type :: Academic Journal
Accession number :: 21208833
Full Text :: https://doi.org/10.1016/j.endonu.2010.10.004

Full Text Access

Tools